Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Novolin 70/30 Flexpen
Novolin 70/30 Flexpen Image

Novolin 70/30 Flexpen

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Novolin 70/30 Flexpen?

Novolin 70/30 FlexPen is a type of insulin medication used to treat diabetes. It falls under the category of human insulin, which means it closely resembles the insulin naturally produced by the human body. Novolin 70/30 FlexPen is produced by Novo Nordisk, a pharmaceutical company known for its expertise in diabetes care. Novolin 70/30 FlexPen consists of a mixture of two types of insulin: intermediate-acting insulin and short-acting insulin. The specific ratio is 70% intermediate-acting insulin (NPH insulin) and 30% short-acting insulin (regular insulin). This combination enables better blood sugar control throughout the day. The FlexPen is a convenient and user-friendly insulin delivery device. It is pre-filled with the Novolin 70/30 insulin mixture and provides an easy way for individuals with diabetes to administer their insulin doses. The pen is designed for multiple uses, allowing the user to dial the desired dosage and administer the injection. It provides a more precise delivery compared to traditional vials and syringes. Novolin 70/30 FlexPen is typically prescribed to individuals with diabetes who require both basal (long-acting) and prandial (mealtime) insulin coverage. It is important to use this medication as directed by a healthcare professional and follow the prescribed dosage and injection instructions. Regular blood sugar monitoring and proper dietary management are important aspects of diabetes care when using Novolin 70/30 FlexPen.

How to use Novolin 70/30 Flexpen?

To use the Novolin 70/30 FlexPen, follow these steps: 1. First, wash your hands thoroughly with soap and water. 2. Remove the pen cap by pulling it straight off. Check the insulin to make sure it is clear and colorless. Do not use the pen if the insulin appears cloudy or discolored. 3. Prime the pen by dialing 2 units, then press the injection button all the way in until you see a drop of insulin at the needle tip. If you don't see a drop, repeat the priming process until you do. 4. Select your dose by turning the dose selector until the correct number of units is shown in the dose window. 5. Clean the injection site with an alcohol swab and let it dry. 6. Pinch the skin at the injection site, insert the needle straight into the skin, and press the injection button all the way down until zero is shown in the dose window. 7. Keep the needle under the skin for 6 seconds to ensure the full dose is delivered. 8. Remove the needle from the skin and dispose of the pen safely. 9. Replace the pen cap to prevent contamination. It is important to note that insulin administration should be done according to your healthcare provider's instructions. Regular monitoring of blood sugar levels, diet, and exercise are also essential components of managing diabetes. Speak to your healthcare provider if you have any questions or concerns about using the Novolin 70/30 FlexPen or managing your diabetes.

Novolin 70/30 Flexpen, a human insulin medication manufactured by Novo Nordisk, comes with several important warnings. These warnings are meant to inform individuals about potential risks and complications associated with its use. It is crucial to consult with a healthcare professional for a comprehensive understanding of these warnings before starting or adjusting the dosage of Novolin 70/30 Flexpen. One significant warning is that Novolin 70/30 Flexpen should not be used during episodes of hypoglycemia (low blood sugar). Administering insulin when blood sugar is already low can further decrease blood sugar levels, leading to severe hypoglycemia. Monitoring blood sugar levels regularly and following a doctor's guidance is crucial to avoid such situations. Another important caution is related to hypersensitivity reactions. Some individuals may experience an allergic reaction to Novolin 70/30 Flexpen. Symptoms of an allergic reaction may include skin rash, itching, swelling, or difficulty breathing. If any of these symptoms occur, immediate medical attention should be sought. Furthermore, it's essential to be aware of the potential for hypokalemia (low potassium levels) or hyperglycemia (high blood sugar levels) while using Novolin 70/30 Flexpen. Healthcare providers may need to adjust the dosage or combine it with other medications to maintain proper blood sugar control. There are also specific precautions for individuals with certain medical conditions. Novolin 70/30 Flexpen should be used with caution in individuals with kidney or liver problems, adrenal, pituitary, or thyroid gland disorders, or in individuals experiencing episodes of diabetic ketoacidosis. They may require close monitoring or adjustments in their treatment plan. An additional warning is that Novolin 70/30 Flexpen may interact with other medications, including certain oral diabetes medications, beta-blockers, or drugs that affect blood sugar levels. It is important to inform the healthcare provider about all medications, vitamins, and supplements being taken to minimize potential interactions. These are just a few of the warnings associated with the use of Novolin 70/30 Flexpen. It is crucial to discuss the full list of warnings, precautions, and other safety information with a healthcare professional before using this medication.

Before taking Novolin 70/30 Flexpen, there are several important warnings and precautions to keep in mind. It is crucial to consult with a healthcare professional for personalized advice. Here is some general information: 1. Allergic reactions: Some individuals may be allergic to Novolin 70/30 Flexpen or its components. Signs of an allergic reaction may include itching, rash, swelling, or difficulty breathing. Seek immediate medical attention in case of an allergic reaction. 2. Hypoglycemia (low blood sugar): Novolin 70/30 Flexpen can cause low blood sugar levels (hypoglycemia). Symptoms include sweating, dizziness, blurred vision, tremors, and confusion. It is important to monitor blood sugar levels regularly and be aware of the signs of low blood sugar. 3. Hyperglycemia (high blood sugar): Novolin 70/30 Flexpen may also cause high blood sugar levels (hyperglycemia). Symptoms of hyperglycemia include frequent urination, increased thirst, blurred vision, and fatigue. Consult a healthcare professional for appropriate management if hyperglycemia occurs. 4. Changes in insulin requirements: Factors such as illness, stress, changes in physical activity, or changes in diet may require adjustments to insulin dosage. Contact a healthcare professional for guidance on insulin dose modification when necessary. 5. Hypokalemia (low potassium levels): Novolin 70/30 Flexpen may cause a decrease in potassium levels. Symptoms of low potassium may include muscle weakness, irregular heartbeat, and muscle cramps. Notify a healthcare professional if such symptoms arise. 6. Drug interactions: Inform your healthcare professional about all medications, including prescription, over-the-counter drugs, and herbal supplements, that you are taking. Certain medications may interact with Novolin 70/30 Flexpen and affect blood sugar levels. 7. Pregnancy and breastfeeding: Consult with a healthcare professional if you are pregnant, planning to become pregnant, or breastfeeding. Insulin requirements may change during these periods, and adjustments to the dosage may be necessary. Always read the medication guide or consult a healthcare professional for complete and personalized information regarding Novolin 70/30 Flexpen.

Novolin 70/30 Flexpen is a medication that contains a mixture of two types of insulin: intermediate-acting insulin and short-acting insulin. It is prescribed to help manage blood sugar levels in individuals with diabetes. Like any medication, Novolin 70/30 Flexpen can cause side effects. Common side effects may include hypoglycemia (low blood sugar), which can cause symptoms such as dizziness, confusion, sweating, and weakness. Other less common side effects may include injection site reactions, such as redness, swelling, or itching at the injection site. It is important to note that everyone's response to medication can vary, and some individuals may experience different side effects or have no side effects at all. If you are experiencing any unusual or severe side effects while using Novolin 70/30 Flexpen, it is important to consult with your healthcare provider for further guidance. They can assess your individual situation and provide appropriate recommendations.

The active ingredients in Novolin 70/30 Flexpen are 70% NPH, Human Insulin Isophane Suspension, and 30% Regular, Human Insulin Injection. NPH insulin is an intermediate-acting insulin that provides a baseline level of insulin throughout the day, while regular insulin is a short-acting insulin that helps to control blood sugar levels after meals. These two types of insulin work together to maintain proper blood sugar control in individuals with diabetes. Novolin 70/30 Flexpen is used to help regulate blood sugar levels in individuals with diabetes mellitus, including both type 1 and type 2 diabetes. In addition to the active ingredients, Novolin 70/30 Flexpen also contains other inactive ingredients that help to stabilize and preserve the medication. These inactive ingredients may include substances like glycerol, zinc chloride, metacresol, phenol, protamine sulfate, sodium hydroxide, and hydrochloric acid. It's important to note that Novolin 70/30 Flexpen should be used as prescribed by a healthcare professional and should not be shared with others. The dosage and administration instructions should be followed carefully, and any questions or concerns should be discussed with a healthcare provider.

For proper storage of Novolin 70/30 Flexpen, it is important to follow the manufacturer's instructions and guidelines. Here are some general recommendations regarding storage: 1. Temperature: Novolin 70/30 Flexpen should be stored in the refrigerator between 36°F and 46°F (2°C - 8°C). Do not freeze the medicine. Freezing can degrade its effectiveness. 2. Room temperature storage: If needed, unopened Novolin 70/30 Flexpen can be kept at room temperature (below 77°F or 25°C) for up to 42 days. However, it is advisable to use it before this time frame to maintain optimal potency. 3. Protection from light: To protect Novolin 70/30 Flexpen from light, you can keep it in the original packaging or place it in a dark, opaque container. 4. Avoid heat exposure: It's important to keep the medication away from excessive heat sources such as direct sunlight, heaters, or hot surfaces. 5. Travel considerations: If you are traveling with Novolin 70/30 Flexpen, make sure to store it properly, following the temperature guidelines mentioned above. Avoid leaving it in a car or any other place where it may be exposed to extreme temperatures. Always check the product label or consult with your healthcare provider for any specific storage recommendations for Novolin 70/30 Flexpen. Proper storage can help maintain the medicine's effectiveness and ensure your safety when using it.

Similar Drugs

Our philosophy is simple — hire a team of diverse, passionate people and foster a culture that empowers you to do your best